Term Clause Example with 19 Variations from Business Contracts
This page contains Term clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "P...rogram"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 for such service.View More
Variations of a "Term" Clause from Business Contracts
Term. The maximum term of each stock option Option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option Option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.1 2 grtx-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.1 Galera Therapeutics, Inc. Non-Employee Director Compensation Program (effective as of February 11, 2021 and amended may 5, 2022) Non-employee members of the bo...ard of directors (the "Board") of Seres Galera Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The As of its effectiveness, the terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Directors, except for equity compensation previously granted to a Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). Director. I. CASH COMPENSATION A. Annual Retainers. Cash Compensation Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following Board (the "Base Retainer") and additional annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving retainers for service as Chairman of the Board or Lead Independent Director or for service on a committee of the Board (each, a "Committee Member Retainer" and together with the Base Retainer, the "Annual Retainers") as follows: Position Amount Base Board Fee $35,000 Chair of the Board or Lead Independent Director $25,000 Chair of Audit Committee $15,000 Chair of Compensation Committee $10,000 Chair of Nominating and Corporate Governance Committee $8,000 Member of Audit Committee (non-Chair) $7,500 Member of Compensation Committee (non-Chair) $5,000 Member of Nominating and Corporate Governance Committee (non-Chair) $4,000 A. Payment of Retainers. For the avoidance of doubt, the Annual Retainers in the table above are additive and a Non-Employee Director shall receive be eligible to earn an additional annual retainer Annual Retainer for each position in which he or she serves. The Annual Retainers shall be earned on a quarterly basis based on a calendar quarter and, except as otherwise provided in Section I(B), shall be paid in cash by the Company in arrears not later than the fifteenth day following the end of $20,000 each calendar quarter. In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the applicable position, for an entire calendar quarter, the Annual Retainer paid to such service. Non-Employee Director pursuant to this Section I(A) shall be prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as applicable. B. Annual Retainer Election. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.3 4 mgtx-20191231ex103e9b315.htm EX-10.3 mgtx_Ex10_3 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.3 MEIRAGTX HOLDINGS PLC NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. MeiraGTx Holdings plc (the "Company") shall r...eceive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $25,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $25,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 US-DOCS\118308717.4 EX-10.3 4 avir-ex103_792.htm EX-10.3 avir-ex103_792.htm Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.3 Atea Pharmaceuticals, Inc. Non-Employee Director Compensation Program (Effective June 18, 2021) Non-employee members of the board of direct...ors (the "Board") of Seres Therapeutics, Atea Pharmaceuticals, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The As of the effective date stated above (the "Effective Date"), the terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual I.Cash Compensation A.Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $25,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 US-DOCS\112651262.2 EX-10.5 3 fixx-ex105_902.htm EX-10.5 fixx-ex105_902.htm Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.5 Homology Medicines, Inc. Non-Employee Director Compensation Program Non-employee members of the board of directors (the "Board") of Seres T...herapeutics, Homology Medicines, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). "Program"), as amended and restated by the Board effective January 1, 2020 (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual I.Cash Compensation A.Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. Board (the Annual Retainer"). B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: retainers (each, a "Committee Member Retainer"): 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $35,000 for such service. View More
Term. The maximum term of each stock share option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 3 EX-10.1 2 knsa-20190930ex101435496.htm EX-10.1 knsa_Ex10_1 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.1 KINIKSA PHARMACEUTICALS, LTD. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. Kiniksa Pharmaceuticals, Ltd.... (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this (as amended effective as of October 1, 2019, this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). hereunder. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "P...rogram"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall will become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock March 1, 2019 (the "Effective Date"). As of the Effective Date, the terms and conditions of this Program will supersede any prior cash and/or equity compensation arrangements for service as a member of the Board that are not legally binding contracts between the Company and any of its Non-Employee Directors. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. Board. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $45,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 |US-DOCS\117796719.7|| EX-10.3 2 sqz-ex10_3.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.3 SQZ Biotechnologies Company Non-Employee Director Compensation Program Non-employee members of the board of directors (the "Board") of Seres Therapeuti...cs, Inc. SQZ Biotechnologies Company (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. service, unless such Non-Employee Director who is serving as Chairman is also serving as the Lead Independent Director. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 3 EX-10.16 3 ex-10d16.htm EX-10.16 tdoc_Ex_10_16 Exhibit 10.4 SERES THERAPEUTICS, 10.16 Effective January 1, 2020 TELADOC HEALTH, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Teladoc Health, Inc. (the "Company") sh...all receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall will become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock January 1, 2020 (the "Effective Date"). As of the Effective Date, the terms and conditions of this Program will supersede any prior cash and/or equity compensation arrangements for service as a member of the Board that are not legally binding contracts between the Company and any of its Non-Employee Directors. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Board.A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $50,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.3 7 d544323dex103.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.3 MEIRAGTX HOLDINGS PLC NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. MeiraGTx Holdings plc (the "Company") shall receive cash and... equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock ordinary shares (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $25,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $25,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.3 10 d877186dex103.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.3 SQZ BIOTECHNOLOGIES COMPANY NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. SQZ Biotechnologies Company (the "Company") shall rec...eive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. service, unless such Non-Employee Director who is serving as Chairman is also serving as the Lead Independent Director. View More
